J Korean Med Assoc.  2015 Apr;58(4):321-329. 10.5124/jkma.2015.58.4.321.

Recent changes in the concept of treatment of insomnia

• Kim L

• KMID: 2194964
• DOI: http://doi.org/10.5124/jkma.2015.58.4.321

Abstract

A consistent diagnosis and classification system is important to ensure a good understanding of the pathophysiology and ultimate treatment of a disorder. Insomnia is one of the more common complaints encountered in the outpatient setting. Despite the prevalence of insomnia, evaluation, treatment, and research has been hampered by a lack of a standard definition of insomnia. In recent years, there have been important advances in the definition and classification of insomnia. The ICSD-3 and DSM-5 sleep-wake disorder classifications have moved away from the causal attributions that were inherent in previous classifications. The aim is simply to acknowledge the bidirectional and interactive effects between sleep disorders and coexisting medical and psychiatric illnesses. When medical and psychiatric illnesses coexist with insomnia, diagnosis of both disorders allows the plan for the management of insomnia to address both issues and apply comprehensive treatment.

Keyword

Insomnia disorder; Definition; Classification; Treatment concept

MeSH Terms

Classification
Diagnosis
Humans
Outpatients
Prevalence
Sleep Initiation and Maintenance Disorders*
Sleep Wake Disorders

Reference

1. American Academy of Sleep Medicine. The international classification of sleep disorders: diagnostic & coding manual. 2nd ed. Westchester: American Academy of Sleep Medicine;2005.

2. National Institutes of Health. National Institutes of Health State of the Science Conference statement on manifestations and management of chronic insomnia in adults, June 13-15, 2005. Sleep. 2005; 28:1049–1057.

3. Ohayon MM, Caulet M, Guilleminault C. How a general population perceives its sleep and how this relates to the complaint of insomnia. Sleep. 1997; 20:715–723.

4. National Heart, Lung, and Blood Institute Working Group on Insomnia. Insomnia: assessment and management in primary care. Am Fam Physician. 1999; 59:3029–3038.

5. Harvey AG. Insomnia: symptom or diagnosis? Clin Psychol Rev. 2001; 21:1037–1059.

6. Hauri PJ, Esther MS. Insomnia. Mayo Clin Proc. 1990; 65:869–882.

7. Goetz CG. Textbook of clinical neurology. 3rd ed. Philadelphia: WB Saunders;2007.

8. Benca RM. Diagnosis and treatment of chronic insomnia: a review. Psychiatr Serv. 2005; 56:332–343.

9. Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002; 6:97–111.

10. Roth T. Insomnia: definition, prevalence, etiology, and consequences. J Clin Sleep Med. 2007; 3:5 Suppl. S7–S10.

11. Lichstein KL, Durrence HH, Taylor DJ, Bush AJ, Riedel BW. Quantitative criteria for insomnia. Behav Res Ther. 2003; 41:427–445.

12. Sateia MJ, Doghramji K, Hauri PJ, Morin CM. Evaluation of chronic insomnia: an American Academy of Sleep Medicine review. Sleep. 2000; 23:243–308.

13. Summers MO, Crisostomo MI, Stepanski EJ. Recent developments in the classification, evaluation, and treatment of insomnia. Chest. 2006; 130:276–286.

14. Reynolds CF 3rd, Kupfer DJ, Buysse DJ, Coble PA, Yeager A. Subtyping DSM-III-R primary insomnia: a literature review by the DSM-IV Work Group on Sleep Disorders. Am J Psychiatry. 1991; 148:432–438.

15. World Health Organization. International statistical classification of diseases and related health problems. 2nd ed. Geneva: World Health Organization;2004.

16. Van Drimmelen-Krabbe JJ, Bradley WG, Orgogozo JM, Sartorius N. The application of the International Statistical Classification of Diseases to neurology: ICD-10 NA. J Neurol Sci. 1998; 161:2–9.

17. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV. 4th ed. Washington, DC: American Psychiatric Association;1994.

18. Mezzich JE. International surveys on the use of ICD-10 and related diagnostic systems. Psychopathology. 2002; 35:72–75.

19. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV-TR. 4th ed. Washington, DC: American Psychiatric Association;2000.

20. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Washington, DC: American Psychiatric Association;2013.

21. American Sleep Disorders Association. The international classification of sleep disorders, revised: diagnostic and coding manual. Rochester: American Sleep Disorders Association;2001.

22. Association of Sleep Disorders Centers and the Association for the Psychophysiological Study of Sleep. Diagnostic classification of sleep and arousal disorders. 1979 first edition. Sleep. 1979; 2:1–154.

23. American Academy of Sleep Medicine. International classification of sleep disorders. 3rd ed. Darien: American Academy of Sleep Medicine;2014.

24. Mathias S, Steiger A, Lancel M. The GABA(A) agonist gaboxadol improves the quality of post-nap sleep. Psychopharmacology (Berl). 2001; 157:299–304.

25. Viola AU, Brandenberger G, Toussaint M, Bouhours P, Paul Macher J, Luthringer R. Ritanserin, a serotonin-2 receptor antagonist, improves ultradian sleep rhythmicity in young poor sleepers. Clin Neurophysiol. 2002; 113:429–434.

26. Mendelson WB, Roth T, Cassella J, Roehrs T, Walsh JK, Woods JH, Buysse DJ, Meyer RE. The treatment of chronic insomnia: drug indications, chronic use and abuse liability. Summary of a 2001 New Clinical Drug Evaluation Unit meeting symposium. Sleep Med Rev. 2004; 8:7–17.

27. Schittecatte M, Dumont F, Machowski R, Cornil C, Lavergne F, Wilmotte J. Effects of mirtazapine on sleep polygraphic variables in major depression. Neuropsychobiology. 2002; 46:197–201.

28. Walsh JK, Erman M, Erwin CW, Jamieson A, Mahowald M, Regestein Q, Scharf M, Tigel P, Vogel G, Ware JC. Subjective hypnotic efficacy of trazodone and zolpidem in DSMIII-R primary insomnia. Hum Psychopharmacol. 1998; 13:191–198.

29. Mouret J, Lemoine P, Minuit MP, Benkelfat C, Renardet M. Effects of trazodone on the sleep of depressed subjects: a polygraphic study. Psychopharmacology (Berl). 1988; 95:S37–S43.

30. Sproule BA, Busto UE, Buckle C, Herrmann N, Bowles S. The use of non-prescription sleep products in the elderly. Int J Geriatr Psychiatry. 1999; 14:851–857.

31. Cooke JR, Ancoli-Israel S. Sleep and its disorders in older adults. Psychiatr Clin North Am. 2006; 29:1077–1093.

32. Hauri P. Case studies in insomnia. New York: Plenum Medical Book;1991.

33. Stepanski EJ, Wyatt JK. Use of sleep hygiene in the treatment of insomnia. Sleep Med Rev. 2003; 7:215–225.

34. Hauri P. The sleep disorders. Kalamazoo: Upjohn;1977.

35. Lacks P, Rotert M. Knowledge and practice of sleep hygiene techniques in insomniacs and good sleepers. Behav Res Ther. 1986; 24:365–368.

36. Edinger JD, Wohlgemuth WK, Radtke RA, Marsh GR, Quillian RE. Cognitive behavioral therapy for treatment of chronic primary insomnia: a randomized controlled trial. JAMA. 2001; 285:1856–1864.

37. Chesson AL Jr, Anderson WM, Littner M, Davila D, Hartse K, Johnson S, Wise M, Rafecas J. Practice parameters for the nonpharmacologic treatment of chronic insomnia. An American Academy of Sleep Medicine report. Standards of Practice Committee of the American Academy of Sleep Medicine. Sleep. 1999; 22:1128–1133.

38. Lacks P, Bertelson AD, Sugerman J, Kunkel J. The treatment of sleep-maintenance insomnia with stimulus-control techniques. Behav Res Ther. 1983; 21:291–295.

39. Spielman AJ, Saskin P, Thorpy MJ. Treatment of chronic insomnia by restriction of time in bed. Sleep. 1987; 10:45–56.

40. Morin CM, Hauri PJ, Espie CA, Spielman AJ, Buysse DJ, Bootzin RR. Nonpharmacologic treatment of chronic insomnia: an American Academy of Sleep Medicine review. Sleep. 1999; 22:1134–1156.

41. Morin CM. Cognitive-behavioral approaches to the treatment of insomnia. J Clin Psychiatry. 2004; 65:Suppl 16. 33–40.

42. Morin CM, Colecchi C, Stone J, Sood R, Brink D. Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA. 1999; 281:991–999.

43. Sateia MJ, Nowell PD. Insomnia. Lancet. 2004; 364:1959–1973.

44. Morgenthaler TI, Lee-Chiong T, Alessi C, Friedman L, Aurora RN, Boehlecke B, Brown T, Chesson AL Jr, Kapur V, Maganti R, Owens J, Pancer J, Swick TJ, Zak R. Standards of Practice Committee of the American Academy of Sleep Medicine. Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders: an American Academy of Sleep Medicine report. Sleep. 2007; 30:1445–1459.

45. Lichstein KL, Wilson NM, Johnson CT. Psychological treatment of secondary insomnia. Psychol Aging. 2000; 15:232–240.

46. Edinger JD, Fins AI, Sullivan RJ, Marsh GR, Dailey DS, Young M. Comparison of cognitive-behavioral therapy and clonazepam for treating periodic limb movement disorder. Sleep. 1996; 19:442–444.

47. Reynolds CF 3rd, O'Hara R. DSM-5 sleep-wake disorders classification: overview for use in clinical practice. Am J Psychiatry. 2013; 170:1099–1101.

48. Ohayon MM, Dauvilliers Y, Reynolds CF 3rd. Operational definitions and algorithms for excessive sleepiness in the general population: implications for DSM-5 nosology. Arch Gen Psychiatry. 2012; 69:71–79.